Approval · Notice of Compliance 2624 · 2001
LANVIS: Notice of Compliance 2624
Issued September 6, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2624
- Date
- September 6, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antileukemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LANVIS | 00282081 | Marketed |
Medicinal ingredients
- THIOGUANINE 40 MG per TAB